Literature DB >> 9805029

The arrogance of science and the pitfalls of hope.

J Hoey.   

Abstract

Mesh:

Year:  1998        PMID: 9805029      PMCID: PMC1232740     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

Review 1.  Unconventional therapies for cancer: 5. Vitamins A, C and E. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-06-02       Impact factor: 8.262

Review 2.  Unconventional therapies for cancer: 6. 714-X. Task Force on Alternative Therapeutic of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-06-16       Impact factor: 8.262

Review 3.  Unconventional therapies for cancer: 1. Essiac. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-04-07       Impact factor: 8.262

4.  Let's abolish the Office of Alternative Medicine of the National Institutes of Health.

Authors:  E C Halperin
Journal:  N C Med J       Date:  1998 Jan-Feb

Review 5.  Unconventional therapies for cancer: 2. Green tea. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-04-21       Impact factor: 8.262

6.  Complementary medicine in Europe.

Authors:  P Fisher; A Ward
Journal:  BMJ       Date:  1994-07-09

7.  Cancer undefeated.

Authors:  J C Bailar; H L Gornik
Journal:  N Engl J Med       Date:  1997-05-29       Impact factor: 91.245

8.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

9.  Prevalence and cost of alternative medicine in Australia.

Authors:  A H MacLennan; D H Wilson; A W Taylor
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

Review 10.  Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment.

Authors:  M Michael; I F Tannock
Journal:  CMAJ       Date:  1998-06-30       Impact factor: 8.262

View more
  2 in total

1.  Proof versus plausibility: rules of engagement for the struggle to evaluate alternative cancer therapies.

Authors:  L J Hoffer
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Discussing complementary therapies: there's more than efficacy to consider.

Authors:  T Truant; M McKenzie
Journal:  CMAJ       Date:  1999-02-09       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.